Sanford Health & MeritCare, a health care system, operates hospitals and clinics in California, Iowa, Minnesota, Nebraska, North Dakota, Oklahoma, Oregon, South Dakota, China, Ghana, and Mexico. It provides services in the areas of allergy and immunology, behavioral health, breast health, cancer/oncology, children's/pediatrics, dermatology and cosmetic services, diabetes and endocrinology, emergency medicine, family medicine, geriatrics, health and wellness, heart/cardiology, internal medicine, laboratory and pathology, medical genetics, neurosciences, and occupational medicine, as well as ear, nose, and throat. The company also provides services in the areas of ophthalmology, orthopedics an...
1305 West 18th Street
PO Box 5039
Sioux Falls, SD 57117-5039
Founded in 1996
Sanford Health Appoints Cornelius Boerkoel as Executive Director of Sanford Imagenetics Research Center
Jan 5 16
Sanford Health announced that Cornelius Boerkoel is joining the company as the executive director of the Sanford Imagenetics Research Center on Genomic and Molecular Medicine. Boerkoel will use his more than 30 years of research and clinical expertise to investigate new ways of expanding Sanford Imagenetics through development of genetic and genomic medicine tools for primary care medical practice at Sanford Health. Boerkoel most recently served as a staff clinician and directed the translational laboratory at the National Institutes of Health Undiagnosed Diseases Program. He is also a co-founder of the Rare Disease Foundation.
Sanford Health Launches System-Wide, EHR-Integrated Pharmacogenetics Service Using Syapse Platform
Jun 4 15
Sanford Health announced the first enterprise-wide availability of real-time drug dosing and order modification alerts tailored to a patient’s genetic profile within a commercial EHR system. The company has automated pharmacogenetic clinical decision support and the internal test process using Syapse Precision Medicine Platform. To provide these services, Sanford Health’s clinical molecular genetics laboratory analyses a custom panel of genes involved in drug metabolism. The Syapse platform delivers clinically actionable drug metabolizer status information to the EHR, where real-time alerts suggest dosage changes or alternative drugs, as appropriate. The company’s integrated health plan will pay for the service, subject to deductibles and copays, which combines genetic testing and EHR-based therapeutic decision support to help clinicians safely prescribe and dose common drugs, including statins, blood thinners, anti-cancer drugs and painkillers. Pharmacogenetic testing is available for all Sanford patients and can be ordered by any Sanford physician, including primary care providers.
Medtronic plc Enters into Patent License Agreement with Sanford Health
Apr 22 15
Medtronic plc has entered into a patent license agreement with Sanford Health to develop a stent graft system for less invasive treatment of thoracoabdominal aortic aneurysms. Sanford Health vascular surgeon Patrick Kelly, MD, developed the concept for the system and has since collaborated with Medtronic to manufacture devices based on the concept. Sanford Health holds the intellectual property covered by the exclusive patent license agreement with Medtronic. Medtronic plans to study the system in collaboration with physicians at several medical centers, including Dr. Kelly at Sanford Health, starting in the near future and subsequently to commercialize it after obtaining the required regulatory approvals.